SRES 781 is a symbolic Senate resolution expressing support for U.S. Olympic and Paralympic teams competing in the 2024 Paris Games. It commends athletes, coaches, and supporters without creating new laws or funding, and affirms commitment to safety for the 2028 Los Angeles Games. The resolution has no policy impact - it serves only to recognize Team USA’s achievements and solidarity. It directly addresses athletes, coaches, and organizers but does not alter any existing programs or obligations.
HRES 1395 is a non-binding House resolution expressing concern that the U.S. is being outpaced by China and Russia in nuclear energy production and global market share. It cites statistics showing China has 56 operational reactors (vs. the U.S.'s 94, including retired ones) and is actively constructing more, while the U.S. has no reactors under construction. The resolution states it is "unacceptable" that the U.S. is no longer dominant in nuclear energy and urges expanding domestic nuclear capacity and supply chains. As a symbolic resolution, it does not create new laws or funding but highlights perceived strategic competition in nuclear technology.
HR 9202, the Nuclear Waste Reprocessing Act, directs the U.S. Department of Energy to create policies supporting the commercial recycling of spent nuclear fuel. It requires the Energy Secretary to work with private industry to advance reprocessing technologies, establish partnerships for research and commercialization, and collaborate with the Nuclear Regulatory Commission to align procedures. The bill mandates annual progress reports to Congress on efforts to develop this technology, aiming to address nuclear waste challenges and position the U.S. as a leader in international reprocessing. It directly affects federal agencies, nuclear energy companies, and the management of nuclear waste materials. The key change is shifting focus toward recycling nuclear fuel components rather than solely storing spent fuel as waste.
This bill requires the U.S. Energy Secretary to conduct a comprehensive evaluation of the domestic nuclear supply chain within 270 days of enactment. The evaluation must assess regulatory hurdles (like N-stamp certification for safety components), explore how advanced technologies (such as 3D printing and AI) could improve efficiency, analyze U.S.-Canada collaboration, and plan for future demand from advanced nuclear reactors. It directly affects nuclear energy companies, manufacturers, and regulators by mandating a federal review to identify supply chain bottlenecks and opportunities for modernization. The bill does not change existing regulations or funding but sets the stage for potential future policy decisions based on the evaluation’s findings.
This bill (HR 9198) updates nuclear licensing rules to require the Nuclear Regulatory Commission (NRC) to use risk-informed and performance-based approaches when making decisions about nuclear facility operations. It amends existing law to define "technology-inclusive regulatory framework" to align with a 1999 NRC document (SRM-SECY-98-144) and mandates annual NRC staff training on these concepts. The bill also includes a non-binding congressional statement emphasizing the importance of shared understanding between the NRC and nuclear industry regarding these regulatory methods. It directly affects NRC staff, nuclear facility operators, and the licensing process for nuclear energy projects.
HR 9199 limits the scope of reviews conducted by the Advisory Committee on Reactor Safeguards (ACRS) under the Atomic Energy Act. It restricts ACRS to only reviewing nuclear license applications involving novel issues or significant safety concerns, based on risk assessments by the committee. The bill also removes ACRS reviews from the Nuclear Regulatory Commission's (NRC) annual fee calculations for license applications. This directly affects the NRC's process for handling license applications and the fee structure for nuclear facility operators seeking approvals.
The STAR Act of 2024 creates a new 25% tax credit for semiconductor companies in the United States, specifically for qualified semiconductor design expenditures. This credit applies to both in-house design costs (like employee wages for design work and supplies used in design) and contracted design work paid to external firms, all conducted within the U.S. The bill directly affects U.S.-based semiconductor manufacturers and design firms by reducing their tax liability for eligible design expenses. The credit is added to the existing advanced manufacturing investment credit, with specific exclusions for non-qualifying activities like cosmetic design or duplicating existing products.
The Nuclear USA Act of 2024 expands tax incentives for nuclear energy infrastructure by amending two key tax provisions. It adds uranium conversion, enrichment, fabrication, and spent fuel reprocessing to the list of qualifying projects under Section 48C of the tax code, directly benefiting companies building or upgrading facilities for these activities. The bill also specifically includes uranium in the advanced manufacturing credit (Section 45X), allowing companies to claim both credits for the same facility - a "double benefit" provision. These changes aim to encourage domestic investment in nuclear fuel supply chains without altering regulatory requirements or imposing new government mandates.
The Respect State Housing Laws Act amends the CARES Act by removing subsection (c) of Section 4024, which governed notice requirements for housing assistance programs. This change eliminates a specific federal notice provision that applied to tenants and landlords receiving CARES Act housing aid. The bill directly affects the administrative process for housing assistance under the CARES Act, streamlining or removing a requirement for notice delivery. It modifies an existing provision without creating new policy or altering broader housing protections.
This bill requires the U.S. President to impose sanctions on foreign individuals and entities that support the Palestinian Authority and Palestine Liberation Organization's system of paying terrorists and their families, which the bill states incentivizes terrorism. Sanctions include blocking U.S. property, denying visas, and restricting financial transactions with officials, organizations (like the Commission of Prisoners), or financial institutions facilitating these payments. The President must act within 90 days of enactment, and sanctions remain in effect until the Secretary of State certifies the payments have ceased. The bill builds on the 2018 Taylor Force Act, which previously tied U.S. aid to ending such payments.
The American Made Pharmaceuticals Act of 2023 establishes a 7-year demonstration program to test giving preferential treatment to drugs manufactured in the United States under Medicare, Medicaid, and CHIP. The program would require federal health programs to use specific tools - such as lower patient cost-sharing, better formulary placement, or waived rebates - for qualifying U.S. manufactured drugs. To qualify, drugs must be made in the U.S. by companies meeting sourcing, transparency, and supply chain resilience standards. The program will run in at least 8 states and require annual reports to Congress on its implementation and outcomes.
This bill permanently removes a 2026 expiration date for a tax exclusion allowing employers to pay employees' student loans through educational assistance programs without those payments being counted as taxable income. It directly affects employees who receive employer-sponsored student loan repayment assistance and employers offering such programs. The key provision amends the Internal Revenue Code to make this tax exclusion permanent, applying to all future payments made after the bill's enactment. This change simplifies the tax treatment for both employers and employees participating in these student loan repayment programs.
